Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene
Duchenne muscular dystrophy is a severe debilitating genetic disease caused by different mutations in the DMD gene leading to the absence of dystrophin protein under the sarcolemma. We used CRISPR-Cas9 prime editing technology for correction of the c.8713C>T mutation in the DMD gene and tested di...
Main Authors: | Cedric Happi Mbakam, Joel Rousseau, Yaoyao Lu, Anne Bigot, Kamel Mamchaoui, Vincent Mouly, Jacques P. Tremblay |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253122002657 |
Similar Items
-
Prime editing strategies to mediate exon skipping in DMD gene
by: Cedric Happi Mbakam, et al.
Published: (2023-05-01) -
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy
by: Cédric Happi Mbakam, et al.
Published: (2022-05-01) -
Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors
by: Michael Gapinske, et al.
Published: (2023-09-01) -
CRISPR-Cas9 correction in the DMD mouse model is accompanied by upregulation of Dp71f protein
by: Tatiana V. Egorova, et al.
Published: (2023-09-01) -
In-Frame Deletion of Dystrophin Exons 8–50 Results in DMD Phenotype
by: Tatiana V. Egorova, et al.
Published: (2023-05-01)